Pipeline · Bill → Law
Step 1
Introduced
Jul 19, 2023
Step 2
Referred
Jul 19, 2023
HELP
Step 3
Committee
Step 4
Senate
Step 5
House floor
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary
This bill requires the Department of Health and Human Services to issue regulations to prevent the misuse of de novo gene synthesis products (i.e., manufactured gene products), including screening protocols for providers of these products. Federal agencies and entities that receive federal funds may only purchase such products from providers that comply with the screening protocols.
Timeline · 2 actions
Jul 19, 2023
Introduced in Senate
Jul 19, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.